Endocrine-Related Cancer

Papers
(The H4-Index of Endocrine-Related Cancer is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Survival following resection of 10,244 lung neuroendocrine tumours: a population study111
Refining long-term surveillance requirements in patients with differentiated thyroid cancer67
Clinical presentation of bone metastases in neuroendocrine tumors: a retrospective cohort study63
Acknowledgement to reviewers56
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas54
Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing41
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications40
Update on the genetics of paragangliomas36
ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression34
Targeting growth hormone in cancer: future perspectives34
Prognostic of recurrence and survival in poorly differentiated thyroid cancer32
Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells31
Metastatic neuroendocrine neoplasms of the breast: a systematic review29
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs29
Chemokines with CXC motif and their receptors in neuroendocrine neoplasms28
Radiation reprograms fibroblasts to drive prostate cancer therapy resistance27
NP-101 in combination with nivolumab and ipilimumab in metastatic extrapulmonary neuroendocrine carcinomas (EP-NECs): A pilot study27
The Diagnostic Value of 68Ga-Pentixafor PET/CT in Differentiating Adrenal Aldosterone-Producing Adenomas from Non-Functional Adenomas24
Defining aging-associated factors that increase susceptibility to prostate cancer24
Impact of sex hormones on development and progression in NEN: a new therapeutic target?23
Metabolically active brown adipose tissue in PPGL: an observational cohort study22
FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination and degradation21
The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas21
Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet21
0.067511081695557